EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

From Claims to Evidence: Re-Evaluating the Molecular Pharmacology of Cirsium japonicum

Kyung-Hee Kim, Tae-Kyung Yeo, Hwa-Seung Yoo iD, Byong Chul Yoo

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27177717 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Kyung-Hee Kim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Chemistry, School of Science and Technology, Kookmin University, Seoul 02707, Republic of Korea. Hauptthemen laut MEDLINE: Cirsium, Plant Extracts. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kookmin University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cirsium japonicum Fisch. ex DC. has long been used in traditional East Asian medicine and has attracted increasing attention because of its diverse pharmacological activities, including antioxidant, anti-inflammatory, antifibrotic, metabolic regulatory, and anticancer effects. Although numerous studies have investigated its phytochemical composition and biological activities, current evidence has largely been organized according to individual compounds or disease categories, providing limited insight into the shared molecular mechanisms underlying its pleiotropic actions. In this review, we critically re-evaluate the molecular pharmacology of C. japonicum using an evidence-oriented framework that distinguishes experimentally supported mechanisms from pharmacological associations and emerging hypotheses. Rather than accepting changes in signaling proteins or downstream biomarkers as sufficient evidence of mechanism, we assess the strength of evidence based on reproducibility, pathway-specific interventions, genetic or pharmacological validation, and direct target engagement. Current evidence indicates that nuclear factor erythroid 2-related factor 2 (Nrf2)-mediated antioxidant responses and nuclear factor kappa B (NF-κB)-associated inflammatory responses represent the most consistently observed pathway associations, although direct molecular targets and causal pathway dependency remain insufficiently established. Evidence for AMPK/PI3K-Akt-associated metabolic regulation and TGF-β/Smad-associated antifibrotic responses is comparatively more limited. In contrast, modulation of apoptosis and autophagy is currently supported primarily by indirect or context-dependent observations. We further discuss how multiple phytochemicals converge on interconnected signaling networks regulating oxidative stress, inflammation, metabolism, tissue remodeling, and cell fate, thereby providing a systems-level explanation for the broad therapeutic potential of C. japonicum. Finally, we highlight the need for standardized phytochemical characterization, rigorous target validation, multi-omics integration, and artificial intelligence-assisted systems biology to establish causal molecular mechanisms and accelerate the translational development of evidence-based phytopharmaceuticals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CirsiumPlant ExtractsHumansSignal TransductionAnimalsPhytochemicalsAntioxidantsAnti-Inflammatory Agents

Stichwörter der Autor:innen

Cirsium japonicumevidence-based medicinemolecular pharmacologynetwork pharmacologyphytochemicalssignal transduction

Substanzen

PhytochemicalsAntioxidantsPlant ExtractsAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Applied Chemistry, School of Science and Technology, Kookmin University, Seoul 02707, Republic of Korea.
  • Antibody Research Institute, Kookmin University, Seoul 02707, Republic of Korea.
  • Oculi Korean Medicine Hospital, Seoul 05655, Republic of Korea.
  • East West Cancer Center, Daejeon Korean Medicine Hospital, Daejeon University, Daejeon 34520, Republic of Korea.
  • Institute of Biotechnology and Bioengineering, Sungkyunkwan University, Suwon 16419, Republic of Korea.

ORCID-Profile: Hwa-Seung Yoo

Förderung

  • Kookmin University

Zitieren

APA

Kim, K. H., Yeo, T. K., Yoo, H. S., & Yoo, B. C. (2026). From Claims to Evidence: Re-Evaluating the Molecular Pharmacology of Cirsium japonicum. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27177717

Vancouver

Kim KH, Yeo TK, Yoo HS, Yoo BC. From Claims to Evidence: Re-Evaluating the Molecular Pharmacology of Cirsium japonicum. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27177717

BibTeX
@article{Kim2026,
  author = {Kim, Kyung-Hee and Yeo, Tae-Kyung and Yoo, Hwa-Seung and Yoo, Byong Chul},
  title = {From Claims to Evidence: Re-Evaluating the Molecular Pharmacology of Cirsium japonicum},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27177717}
}
Kostenlos starten →